| Product Code: ETC12463394 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Imatinib Drug Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Imatinib Drug Market - Industry Life Cycle |
3.4 Poland Imatinib Drug Market - Porter's Five Forces |
3.5 Poland Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Poland Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Poland Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Poland Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Poland Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Poland Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in Poland |
4.2.2 Growing awareness about the effectiveness of imatinib in treating CML |
4.2.3 Favorable government regulations supporting access to innovative cancer treatments |
4.3 Market Restraints |
4.3.1 High cost associated with imatinib therapy |
4.3.2 Stringent regulatory requirements for drug approval and market entry |
5 Poland Imatinib Drug Market Trends |
6 Poland Imatinib Drug Market, By Types |
6.1 Poland Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Poland Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Poland Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Poland Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Poland Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Poland Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Poland Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Poland Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Poland Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Poland Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Poland Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Poland Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Poland Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Poland Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Poland Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Poland Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Poland Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Poland Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Poland Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Poland Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Poland Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Poland Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Poland Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Poland Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Poland Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Poland Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Poland Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Poland Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Poland Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Poland Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Poland Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Poland Imatinib Drug Market Import-Export Trade Statistics |
7.1 Poland Imatinib Drug Market Export to Major Countries |
7.2 Poland Imatinib Drug Market Imports from Major Countries |
8 Poland Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib treatment |
8.2 Percentage of CML patients switching to imatinib therapy |
8.3 Number of healthcare providers prescribing imatinib as a first-line treatment option |
9 Poland Imatinib Drug Market - Opportunity Assessment |
9.1 Poland Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Poland Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Poland Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Poland Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Poland Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Poland Imatinib Drug Market - Competitive Landscape |
10.1 Poland Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Poland Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here